Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway?
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Transforming growth factor‐β (TGF‐β), a multifunctional cytokine, has been widely suggested to play a role in the pathogenesis of Alzheimer's disease. Supporting this, levels of TGF‐β are elevated in the cerebrospinal fluid, sera, and brain of patients with Alzheimer's disease. Since TGF‐β is neuroprotective, whereas Alzheimer's disease is typified by neurodegeneration, we speculated that defects in TGF‐β signaling might abrogate its neuroprotective properties. Consistently with an increase in TGF‐β in Alzheimer's disease, we found significant increases in phospho‐Smad2, a major downstream signaling molecule of TGF‐β, in hippocampal neurons of Alzheimer's disease compared with age‐matched control patients. However, in contrast to an expected nuclear localization, phosphorylated Smad2 in Alzheimer's disease was predominantly, and ectopically, found in the neuronal cytoplasm, specifically colocalized with neurofibrillary tangles and granulovacuolar degeneration. Given that a nuclear localization is required to regulate the transcription of TGF‐β target genes to afford neuroprotection, the ectopic localization of phosphorylated Smad2 suggests a defect in the Smad‐mediated signaling pathway of TGF‐β in Alzheimer's disease and consequent loss of neuroprotective function. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 2×
“The optical density from five representative control and AD cases was determined with a Axiovision 4.5 Analysis System (Zeiss) connected to the Axiocam digital camera attached to the Axiophot microscope as previously described (Nunomura et al., 2001).”
MethodInfluentialSelf-citationHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease
Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., & Mucke, L. (1997) · Nature · doi:10.1038/39321 · Cited by 417 · cited 1×
“Several studies have also indicated that TGF-b up-regulates the expression of the amyloid-b protein precursor (AbPP) gene and, therefore, the pathogenesis of AD (van der Wal et al., 1993; Peress and Perillo, 1995; Mattson et al., 1997; Wyss-Coray et al., 1997; Burton et al., 2002).”
BackgroundZhu, X., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.880 · Cited by 378 · cited 1×
“…it is possible that all or any of these signaling cascades could be mediating the protective effects of TGF-b in neurons, and such a notion would be consistent with increases in Bcl-w proteins (Zhu et al., 2004), ERK (Perry et al., 1999), p38 (Zhu et al., 2000), and JNK (Zhu et al., 2001a) in AD.”
BackgroundSelf-citation
Cited by
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Singh, D. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02565-0 · Cited by 569
Aging‐dependent changes of microglial cells and their relevance for neurodegenerative disorders
Von Bernhardi, R., Tichauer, J. E., & Eugenín, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06537.x · Cited by 258
Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172
Pereira Diniz, L., Tortelli, V., Matias, I., Morgado, J., Bérgamo Araujo, A. P., Melo, H. M., Seixas da Silva, G. S., Alves-Leon, S. V., de Souza, J. M., Ferreira, S. T., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3351-16.2017 · Cited by 171
“Additionally, deficits in TGF- pathways have been reported in AD brains, in the brains of aged mice, and in mouse models of AD (Lee et al., 2006; Tesseur et al., 2006; Ueberham et al., 2006; Chalmers and Love, 2007; Tichauer et al., 2014; Caraci et al., 2015).”
BackgroundMicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
Kumar, S., Vijayan, M., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx267 · Cited by 167
Metadata
- Authors
- Lee, H., Ueda, M., Zhu, X., Perry, G., & Smith, M. A.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2006-09-22
- Volume
- 84
- Issue
- 8
- Pages
- 1856-1861
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2012700666
- Cited by
- 72
- References
- 4
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway? https://app.cochat.ai/papers/10.1002/jnr.21072
- The paper
- Lee, H., Ueda, M., Zhu, X., Perry, G., & Smith, M. A. (2006). Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway? Journal of Neuroscience Research. https://doi.org/10.1002/jnr.21072
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.